Neonatal diabetes mellitus: current perspective

References

• Polak M, Cavé H. Neonatal diabetes mellitus: a disease linked to multiple mechanisms. Orphanet. J Rare Dis. 2007;2:12.
   PubMed Web of Science ®Google Scholar
• Grulich-Henn J, Wagner V, Thon A, et al. Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV). Diabet Med. 2010;27(6):709–712.
   Web of Science ®Google Scholar
• Aguilar-Bryan L, Bryan J. Neonatal diabetes mellitus. Endocr Rev. 2008;29(3):265–291.
   PubMed Web of Science ®Google Scholar
• Temple IK, James RS, Crolla JA, et al. An imprinted gene(s) for diabetes? Nat Genet. 1995;9(2):110–112.
   Web of Science ®Google Scholar
• Gardner RJ, Mackay DJ, Mungall AJ, et al. An imprinted locus associated with transient neonatal diabetes mellitus. Hum Mol Genet. 2000;9(4):589–596.
   PubMed Web of Science ®Google Scholar
• Mackay DJ, Temple IK. Transient neonatal diabetes mellitus type 1. Am J Med Genet C Semin Med Genet. 2010;154C(3):335–342.
   PubMed Web of Science ®Google Scholar
• Abdollahi A. LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions. J Cell Physiol. 2007;210(1):16–25.
   PubMed Web of Science ®Google Scholar
• Flanagan SE, Patch AM, Mackay DJ, et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes. 2007;56(7):1930–1937.
   PubMed Web of Science ®Google Scholar
• Yorifuji T, Kurokawa K, Mamada M, et al. Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: Phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1beta gene due to germline mosaicism. J Clin Endocrinol Metab. 2004;89(6):2905–2908.
   Google Scholar
• Edghill EL, Bingham C, Slingerland AS, et al. Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development. Diabet Med. 2006;23(12):1301–1306.
   PubMed Web of Science ®Google Scholar
• Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab. 2008;4(4):200–213.
   Google Scholar
• Babenko AP, Polak M, Cavé H, et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med. 2006;355(5):456–466.
   PubMed Web of Science ®Google Scholar
• Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes. 2005;54(9):2503–2513.
   PubMed Web of Science ®Google Scholar
• Shah B, Breidbart E, Pawelczak M, Lam L, Kessler M, Franklin B. Improved long-term glucose control in neonatal diabetes mellitus after early sulfonylurea allergy. J Pediatr Endocrinol Metab. 2012;25(3–4):353–356.
   Google Scholar
• Zwaveling-Soonawala N, Hagebeuk EE, Slingerland AS, Ris-Stalpers C, Vulsma T, van Trotsenburg AS. Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation. Diabetologia. 2011;54(2):469–471.
   Web of Science ®Google Scholar
• Maassen JA, ‘T Hart LM, Van Essen E, et al. Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes. 2004;53 Suppl 1:S103–S109.
   Google Scholar
• Woolley SL, Saranga S. Neonatal diabetes mellitus: A rare but important diagnosis in the critically ill infant. Eur J Emerg Med. 2006;13(6):349–351.
   Web of Science ®Google Scholar
• Abaci A, Razi CH, Ozdemir O, et al. Neonatal diabetes mellitus accompanied by diabetic ketoacidosis and mimicking neonatal sepsis: a case report. J Clin Res Pediatr Endocrinol. 2010;2(3):131–133.
   Google Scholar
• Gloyn AL, Pearson ER, Antcliff JF, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med. 2004;350(18):1838–1849.
   PubMed Web of Science ®Google Scholar
• Lee JH, Tsai WY, Chou HC, Tung YC, Hsieh WS. Permanent neonatal diabetes mellitus manifesting as diabetic ketoacidosis. J Formos Med Assoc. 2003;102(12):883–886.
   Web of Science ®Google Scholar
• Metz C, Cavé H, Bertrand AM, et al; NDM French Study Group. Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases. J Pediatr. 2002;141(4):483–489.
   Web of Science ®Google Scholar
• Meetze W, Bowsher R, Compton J, Moorehead H. Hyperglycemia in extremely- low-birth-weight infants. Biol Neonate. 1998;74(3):214–221.
   Google Scholar
• Ogilvy-Stuart AL, Beardsall K. Management of hyperglycaemia in the preterm infant. Arch Dis Child Fetal Neonatal Ed. 2010;95(2):F126–F131.
   Web of Science ®Google Scholar
• Fosel S. Transient and permanent neonatal diabetes. Eur J Pediatr. 1995;154(12):944–948.
   Web of Science ®Google Scholar
• Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, et al. Prevalence and determinants of hyperglycemia in very low birth weight infants: cohort analyses of the NIRTURE study. J Pediatr. 2010;157(5):715–719. e1.
   PubMed Web of Science ®Google Scholar
• Iafusco D, Stazi MA, Cotichini R, et al; Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology. Permanent diabetes mellitus in the first year of life. Diabetologia. 2002;45(6):798–804.
   Web of Science ®Google Scholar
• De León DD, Stanley CA. Permanent neonatal diabetes mellitus. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, editors. GeneReviews™. Seattle, WA: University of Washington; 1993.
   Google Scholar
• Rubio-Cabezas O, Klupa T, Malecki MT; CEED3 Consortium. Permanent neonatal diabetes mellitus – the importance of diabetes differential diagnosis in neonates and infants. Eur J Clin Invest. 2011;41(3):323–333.
   Web of Science ®Google Scholar
• Ellard S, Flanagan SE, Girard CA, et al. Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. Am J Hum Genet. 2007;81(2):375–382.
   PubMed Web of Science ®Google Scholar
• Pearson ER, Flechtner I, Njølstad PR, et al; Neonatal Diabetes International Collaborative Group. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006;355(5):467–477.
   PubMed Web of Science ®Google Scholar
• Rafiq M, Flanagan SE, Patch AM, Shields BM, Ellard S, Hattersley AT; Neonatal Diabetes International Collaborative Group. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care. 2008;31(2):204–209.
   Web of Science ®Google Scholar
• Wolfsdorf J, Glaser N, Sperling MA; American Diabetes Association. Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association. Diabetes Care. 2006;29(5):1150–1159.
   PubMed Web of Science ®Google Scholar
• Wolfsdorf J, Craig ME, Daneman D, et al. Diabetic ketoacidosis in children and adolescents with diabetes. Pediatr Diabetes. 2009;10(Suppl 12):S118–S133.
   PubMed Web of Science ®Google Scholar
• Martin RJ, Fanaroff AA, Walsh MC, editors. Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. 9th ed. St Louis, MO: Mosby; 2011:1497–1620.
   Google Scholar
• Sarici SU, Alpay F, Dündaryz MR, Gyknay E. Neonatal diabetes mellitus: patient report and review of the literature. J Pediatr Endocrinol Metab. 2001;14(4):451–454.
   Google Scholar
• Bharucha T, Brown J, McDonnell C, et al. Neonatal diabetes mellitus: Insulin pump as an alternative management strategy. J Paediatr Child Health. 2005;41(9–10):522–526.
   Web of Science ®Google Scholar
• Jeha GS, Venkatesh MP, Edelen RC, Kienstra KA, Karaviti L, Fernandes CJ. Neonatal diabetes mellitus: patient reports and review of current knowledge and clinical practice. J Pediatr Endocrinol Metab. 2005;18(11):1095–1102.
   Google Scholar
• Mitamura R, Kimura H, Murakami Y, Nagaya K, Makita Y, Okuno A. Ultralente insulin treatment of transient neonatal diabetes mellitus. J Pediatr. 1996;128(2):268–270.
   Web of Science ®Google Scholar
• Rosenzweig JL. The use of diluted insulin. Diabetes Technol Ther. 2000;2(1):67–68.
   Google Scholar
• Stickelmeyer MP, Graf CJ, Frank BH, Ballard RL, Storms SM. Stability of U-10 and U-50 dilutions of insulin lispro. Diabetes Technol Ther. 2000;2(1):61–66.
   Google Scholar
• Wintergerst KA, Hargadon S, Hsiang HY. Continuous subcutaneous insulin infusion in neonatal diabetes mellitus. Pediatr Diabetes. 2004;5(4):202–206.
   Web of Science ®Google Scholar
• Beardsall K, Ogilvy-Stuart AL, Ahluwalia J, Thompson M, Dunger DB. The continuous glucose monitoring sensor in neonatal intensive care. Arch Dis Child Fetal Neonatal Ed. 2005;90(4):F307–F310.
   Web of Science ®Google Scholar
• Gribble FM, Reimann F. Sulphonylurea action revisited: the post-cloning era. Diabetologia. 2003;46(7):875–891.
   PubMed Web of Science ®Google Scholar
• Chakera AJ, Flanagan SE, Ellard S, Hattersley AT. Comment on: Khurana et al. The diagnosis of neonatal diabetes in a mother at 25 years of age. Diabetes Care. 2012;35:e59. Diabetes Care. 2013;36(2):e31.
   Web of Science ®Google Scholar
• Ješić MM, Ješić MD, Maglajlić S, Sajić S, Necić S. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation. Diabetes Res Clin Pract. 2011;91(1):e1–e3.
   Web of Science ®Google Scholar
• Turkkahraman D, Bircan I, Tribble ND, Akçurin S, Ellard S, Gloyn AL. Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy. J Pediatr. 2008;153(1):122–126.
   PubMed Web of Science ®Google Scholar
• Slingerland AS, Nuboer R, Hadders-Algra M, Hattersley AT, Bruining GJ. Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene. Diabetologia. 2006;49(11):2559–2563.
   PubMed Web of Science ®Google Scholar
• Slingerland AS, Hurkx W, Noordam K, et al. Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation. Diabet Med. 2008;25(3):277–281.
   PubMed Web of Science ®Google Scholar
• Greeley SA, Tucker SE, Worrell HI, Skowron KB, Bell GI, Philipson LH. Update in neonatal diabetes. Curr Opin Endocrinol Diabetes Obes. 2010;17(1):13–19.
   Google Scholar
• Babiker T, Shepherd MH, Hattersley AT. Continue with long term sulfonylureas in patients with mutations in the KCNJ11 gene when there is evidence of response even if insulin treatment is still required. Diabetes Res Clin Pract. 2013;100(3):e63.
   Web of Science ®Google Scholar
• Russo C, Salina A, Aloi C, Iafusco D, Lorini R, d’Annunzio G. Mother and daughter carrying the same KCNJ11 mutation but with a different response to switching from insulin to sulfonylurea. Diabetes Res Clin Pract. 2011;94(2):e50–e52.
   Web of Science ®Google Scholar
• Codner E, Flanagan S, Ellard S, García H, Hattersley AT. High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation. Diabetes Care. 2005;28(3):758–759.
   Web of Science ®Google Scholar
• Kumaraguru J, Flanagan SE, Greeley SA, et al. Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect. Diabetes Care. 2009;32(8):1428–1430.
   Web of Science ®Google Scholar
• Iafusco D, Bizzarri C, Cadario F, et al. No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes. Diabetologia. 2011;54(10):2736–2738.
   Web of Science ®Google Scholar
• Codner E, Flanagan SE, Ugarte F, et al. Sulfonylurea treatment in young children with neonatal diabetes: dealing with hyperglycemia, hypoglycemia, and sick days. Diabetes Care. 2007;30(5):e28–e29.
   Google Scholar
• Silverstein J, Klingensmith G, Copeland K, et al; American Diabetes Association. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005;28(1):186–212.
   PubMed Web of Science ®Google Scholar
• Temple IK, Shield JP. Transient neonatal diabetes, a disorder of imprinting. J Med Genet. 2002;39(12):872–875.
   Web of Science ®Google Scholar
• von Mühlendahl K, Herkenhoff H. Long-term course of neonatal diabetes. N Engl J Med. 1995;333(11):704–708.
   Web of Science ®Google Scholar